Role of Artificial Intelligence in the Diagnosis of Dementia in the Elderly
Main Article Content
Abstract
Dementia, a progressive neurodegenerative disorder affecting memory, cognition, and behaviour, poses a major global health challenge in aging populations. The complexity of early diagnosis and the subtle onset of symptoms often delay intervention. In recent years, artificial intelligence (AI) has emerged as a transformative tool for the early detection, classification, and monitoring of dementia, particularly Alzheimer’s disease. AI-driven models leveraging neuroimaging, clinical data, speech analysis, and digital biomarkers are redefining diagnostic accuracy and efficiency. This review highlights the current advancements, methodologies, and challenges in the application of AI for dementia diagnosis in the elderly, and discusses its implications for clinical practice and future research.
References
Wang Y, Chen HJ, Cheng Y, Xie Y, Cheng Y, Zhao S, Jiang Y, Bai T, Huo Y, Wang K, Zhang M, Huang W, Feng G, Han Y, Shu N. Multimodal Integration of Plasma Biomarkers, MRI, and Genetic Risk to Predict Cerebral Amyloid Burden in Alzheimer's Disease. Neuroimage. 2025 Oct 22:121550. doi: 10.1016/j.neuroimage.2025.121550. Epub ahead of print. PMID: 41135743.
Ishikawa KM, Uechi M, Ahn HJ, Lim E. Screening mild cognitive impairment using aspects of personal, social, and functional lifestyle: Machine Learning Approaches. PLoS One. 2025 Oct 24;20(10):e0334704.
Fernandes S, Rosselet Amoussou J, Gomes da Rocha C, Perruchoud E, von Gunten A, Mabire C, Verloo H. Using Artificial Intelligence-Based Technologies for the Early Detection of Behavioral and Psychological Symptoms of Dementia: Scoping Review. JMIR Aging. 2025 Oct 21;8:e76074.
Alhasan MS, Alhasan AS, Milburn J, Khalil M, Almaghraby A, Alharthi O, Hamoud S, Essibayi MA, Elhassan YH, Feltrin F, Singh S, Azzam AY. FDG-PET brain glucose hypometabolism predicts Alzheimer's disease progression pathways in cognitively normal adults: Alongitudinal competing risks modeling. Metabol Open. 2025 Sep 26;28:100400.
Esteva, A., Robicquet, A., Ramsundar, B.et al.A guide to deep learning in healthcare.Nat Med25, 24–29 (2019).
Rathore S, Habes M, Iftikhar MA, Shacklett A, Davatzikos C. A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages. Neuroimage. 2017 Jul 15;155:530-548.
Livingston, Jonathan Huntley, Andrew Sommerlad, David Ames, Clive Ballard, Sube Banerjee, Carol Brayne, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper, Sergi G Costafreda, Amit Dias, Nick Fox, Laura N Gitlin, Robert Howard, Helen C Kales, Mika Kivimäki, Eric B Larson, Adesola Ogunniyi, Vasiliki Orgeta, Karen Ritchie, Kenneth Rockwood, Elizabeth L Sampson, Quincy Samus, Lon S Schneider, Geir Selbæk, Linda Teri, Naaheed Mukadam. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission Gill. Vol 396 August 8, 2020, 413-446
Hanumanthachar Joshi, SandhyaP, Anirudh Joshi K. Machine learning in pharmacy and health care revolutionizing patient outcomes. International Journal of Innovative Research in Technology. 12(1), 2025, 2719-2722
